Bone Biologics Corp
BBLG- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001419554
No open-market purchases or sales by Bone Biologics Corp insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $35.7K in total; no superinvestor holds it.
Key figures
- Market capCalculated value looks implausible
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 3
- 13F valueReported value at the end of Q2 2026
- $35.7K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- –
- No comparable prior period
- Net income, FY2025
- -$3.11M
- No comparable prior period
- Free cash flow, FY2025
- –
- No comparable prior period
- Revenue, Q3 FY2026
- –
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 17.6K
- Shares sold short
- Change
- −5.14K
- −22.6% vs. previous
- Days to cover
- 1.00
- At average daily volume
Superinvestors holding BBLG, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding BBLG at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Bone Biologics Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2023 (view filing) | Sep 13 | 1 day | Walsh Deina HChief Financial Officer | PPurchase | +8.00K | $0.64 | +$5.12K | +114.3%15.0K after | |
| Sep 12, 2023 (view filing) | Sep 11 | 1 day | Frelick JeffChief Executive Officer | PPurchase | +9.50K | $0.69 | +$6.55K | +123.3%17.2K after | |
| Sep 7, 2023 (view filing) | Sep 6 | 1 day | Walsh Deina HChief Financial Officer | PPurchase | +7.00K | $0.7096 | +$4.97K | New position7.00K after | 2 lots |
| Sep 5, 2023 (view filing) | Aug 31 | 5 days | Frelick JeffChief Executive Officer | PPurchase | +7.60K | $0.66 | +$5.02K | +7,307.7%7.70K after |
Top 10 13F holders, Q2 2026
See all 3 holdersThe largest institutional positions in Bone Biologics Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 23,879 | $32.7K | 0.00% | +23,879 | New |
| Tower Research Capital LLC (TRC) | 1,953 | $2.68K | 0.00% | −2,173−52.7% | Reduced |
| SBI Securities Co., Ltd. | 230 | $315 | 0.00% | 00.0% | Unchanged |
Holders of 5% or more of BBLG
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Bone Biologics Corp.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Intracoastal Capital, LLC | 13G/A | 9.99%305.9K shares | 0.00 ppfrom 9.99% | Nov 27, 20236 filings | Nov 10, 2026 | SEC |